Abattis Bioceuticals (Abattis Bioceuticals) Accounts Payable & Accrued Expense : $2.62 Mil (As of Sep. 2019)

View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals Accounts Payable & Accrued Expense?

Abattis Bioceuticals's quarterly accounts payable & accrued expense increased from Mar. 2019 ($0.24 Mil) to Jun. 2019 ($2.74 Mil) but then declined from Jun. 2019 ($2.74 Mil) to Sep. 2019 ($2.62 Mil).

Abattis Bioceuticals's annual accounts payable & accrued expense declined from Sep. 2017 ($0.36 Mil) to Sep. 2018 ($0.23 Mil) but then increased from Sep. 2018 ($0.23 Mil) to Sep. 2019 ($2.62 Mil).

Abattis Bioceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Abattis Bioceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals Accounts Payable & Accrued Expense Chart

Abattis Bioceuticals Annual Data

Trend

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.84

0.78

0.36

0.23

2.62

Abattis Bioceuticals Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.23	0.28	0.24	2.74	2.62

Abattis Bioceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6

Website

http://www.abattis.com

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.